Your Directors have immense pleasure in presenting the 34th (Thirty Fourth) Annual Report on the business and operations of the Companytogether with the Audited Standalone and Consolidated Financial Statements for the financial year ended 31st March, 2025.
The Company's financial performance (Standalone and Consolidated) for FY 2024-25 is summarized below:
Particulars
Standalone |
Consolidated
For the FinancialYear ended31st March, 2025
For the FinancialYear ended31st March, 2024
Revenue from Operation
39,249.01
35,645.97
43,848.71
39,598.47
Other Income
776.00
407.64
781.63
401.77
Profit for the year before Finance Cost,Depreciation, Exceptional Items and Tax
6,600.79
5,646.74
6,041.13
5,070.15
Less: Finance Cost
77.73
141.51
154.56
270.17
Less: Depreciation and Amortization Expenses
1,691.36
1,506.35
1,847.45
1,644.87
Profit before Exceptional Items and Tax
4,831.70
3,998.88
4,039.12
3,155.11
Less: Exceptional Item
Profit before tax
Less: Tax Expenses
1,330.04
852.95
1,366.80
806.96
Profit after tax
3,501.66
3,145.93
2,672.32
2,348.15
Other Comprehensive Income
7.71
(17.17)
(21.24)
(20.64)
Total Comprehensive Income for the year
3,509.37
3,128.76
2,651.08
2,327.51
The above figures are extracted from the Audited Standalone and Consolidated Financial Statements prepared in accordance withaccounting principles generally accepted in India as specified under Sections 129 and 133 of the Companies Act, 2013 ("the Act") read withthe Companies (Accounts) Rules, 2014, as amended and other relevant provisions of the Act and guidelines issued by the Securities andExchange Board of India ("SEBI").
The Financial Statements as stated above are available on the Company's website at Financials.
a) Standalone
During the FY 2024-25, the Company achieved Revenuefrom Operations of '39,249.01 lakhs as against '35,645.97lakhs in FY 2023-24, representing a growth of 10.11%. TheProfit before Finance Cost, Depreciation and Amortizationexpenses and Exceptional Items for the year amounted to'6,600.79 lakhs, representing EBITDA margin of 16.82%, anincrease by 16.90%, as compared to the previous financialyear. The EBIT margin of the Company during FY 2024-25was 12.51%. The Company earned Other Income of '776.00lakhs during FY 2024-25 as compared to '407.64 lakhsin FY 2023-24 (mainly from interest income and incomefrom investments). The Company recorded Profit BeforeTax of '4,831.70 lakhs in FY 2024-25 as compared to'3,998.88 lakhs in FY 2023-24. Profit After Tax (PAT) duringFY 2024-25 was '3,501.66 lakhs as against '3,145.93 lakhsin the FY 2023-24, showing a growth of 11.31%. The effectivetax rate for FY 2024-25, including provisions for deferred taxwas 27.53%, as compared to an effective tax rate of 21.33%during FY 2023-24. As of 31st March, 2025, the Company hadnet cash of '11,475.46 lakhs.
b) Consolidated
During the FY 2024-25, the Company achieved Revenuefrom Operations of '43,848.71 lakhs as against '39,598.47lakhs in FY 2023-24, representing a growth of 10.73%. TheProfit before Finance Cost, Depreciation and Amortizationexpenses and Exceptional Items for the year amounted to'6,041.13 lakhs, representing EBITDA margin of 13.78%, anincrease by 0.97%, as compared to the previous financialyear. The EBIT margin of the Company during FY 2024-25 was9.56%. The Company earned Other Income of '781.63 lakhsin FY 2024-25 as compared to '401.77 lakhs in FY 2023-24(mainly from interest income and income from investments).The Company recorded Profit Before Tax of '4.039.12lakhs in FY 2024-25 as compared to '3,155.11 lakhs in FY
2023- 24. Profit After Tax (PAT) during FY 2024-25 was'2,672.32 lakhs as against '2,348.15 lakhs in the FY 2023¬24, showing a growth of 13.81%. The effective tax rate for FY
2024- 25, including provisions for deferred tax was 33.84%, ascompared to an effective tax rate of 25.58% during FY 2023¬24. As of 31st March, 2025, the Company had net cash of'10,633.75 lakhs.
There have been no material changes and commitments affectingthe Company's financial position, between the end of the financialyear and the date of this Report.
The Board of Directors of the Company have not declared anydividend for the year under review, to conserve the resources of theCompany for its future growth.
The Company does not fall within the top 1000 listed entitiesbased on the market capitalziation as on 31st December, 2024.However, the Board of Directors of the Company have voluntaryadopted and approved the Dividend Distribution Policy in linewith Regulation 43A of SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 ("SEBI Listing Regulations"),which has been uploaded on the Company's website at DividendDistribution Policy.
During the year under review, the Company has not transferred anyamount to General Reserves.
During the year under review and as on the date of this report,your Company does not have any holding, associate / joint venturecompany.
Goel Scientific Glass Works Limited ("GSGWL") continues to remaina material subsidiary of the Company in terms of Regulation 16(c) ofthe SEBI Listing Regulations. GSGWL is engaged in manufacturingand supply of industrial glass process systems and laboratoryglassware. Your Company holds 2,16,10,880 equity shares of '10each (representing 99.03% of equity share capital) in GSGWL.
The Company has formulated a Policy for determining materialsubsidiaries. The said policy is available on the Company'swebsite and can be accessed at Policy for Determining MaterialSubsidiaries.
During FY 2024-25, GSGWL achieved a Revenue from Operationsof '4,928.08 lakhs as against '4,415.18 lakhs in FY 2023-24,registering a growth of 11.61% on a year-on-year basis. The lossafter tax for FY 2024-25 stood at '699.41 lakhs as against '866.12lakhs in FY 2023-24. Despite the increase in revenue, GSGWLcontinued to report losses, although lower compared to theprevious year. The losses were primarily attributable to one-timeexpenses of provisions for doubtful debts of '1.63 crores andunder-absorption of fixed overheads, which could be recoveredwith higher sales.
A statement providing details of performance and salient featuresof the financial statements of GSGWL, as per Section 129(3) of theAct, is provided as Annexure to the Consolidated Audited FinancialStatement and therefore not repeated in this Report to avoidduplication.
The audited financial statements of GSGWL, are available on theCompany's website and can be accessed at Subsidiary Financials.
In accordance with the provisions of the Act and SEBI ListingRegulations read with Ind AS - 110 - Consolidated FinancialStatements, the Consolidated Audited Financial Statement formspart of the Annual Report.
Pursuant to the provisions of Section 136 of the Act, the AuditedStandalone and Consolidated Financial Statements of the Companyalong with relevant documents and the Financial Statement of theSubsidiary Company are available on the Company's website atFinancials and Subsidiary Financials.
Any member desirous of obtaining copies of the FinancialStatement of the Subsidiary Company may write an e-mail tobsl.secretarial@borosil.com up to the date of the ensuing AnnualGeneral Meeting ("AGM").
During the year under review, your Company implemented thefollowing Employee Stock Option Schemes, in compliancewith the Securities and Exchange Board of India (Share BasedEmployee Benefits and Sweat Equity) Regulations, 2021 ("SBEBRegulations"):
• Special Purpose Employee Stock Option Plan 2023("SP - ESOP 2023"); and
• Borosil Scientific Limited - Employee Stock Option Scheme("BSL ESOS").
The Nomination & Remuneration Committee administers andmonitors SP - ESOP 2023 and BSL ESOS. The Company hasobtained a certificate from M/s. Amogh Diwan & Associates,Practicing Company Secretaries, Secretarial Auditor of theCompany, confirming that the ESOP Schemes viz. SP - ESOP2023 and BSL ESOS have been implemented in accordance withSBEB Regulations and the resolutions passed by the Board ofDirectors and the Members, as applicable, respectively. Thiscertificate will be available for inspection by the Members duringthe AGM.
The details as required to be disclosed under Regulation 14 ofSBEB Regulations in respect of SP - ESOP 2023 and BSL ESOS, areavailable on the Company's website at ESOP Disclosures.
During the year under review, the paid-up equity share capitalof the Company has increased from '8,87,96,392/- consistingof 8,87,96,392/- fully paid-up equity shares of '1/- each to'8,89,33,303/- consisting of 8,89,33,303 fully paid-up equity sharesof '1/- each, consequent to allotment of 1,36,911 equity shares offace value of '1/- each upon exercise of stock options under SP -ESOP 2023.
During the year under review, the Company has not issued shareswith differential voting rights, sweat equity shares, shares held intrust for the benefit of employees where the voting rights are notexercised directly by the employees, debentures, bonds or any non¬convertible securities and warrants.
The Management Discussion and Analysis Report for the yearunder review, as required in terms of SEBI Listing Regulations,forms part of this Report as 'Annexure - A’.
The Company is committed to maintain the highest standards ofCorporate Governance and adhering to the Corporate Governancerequirements and transparency in all its dealings and places highemphasis on business ethics.
A Report on Corporate Governance as per Regulation 34 readwith Schedule V to the SEBI Listing Regulations along withthe Compliance Certificate from the M/s. Chaturvedi & ShahLLP, Chartered Accountants (Firm Registration No. 101720W/W100355), Statutory Auditor of the Company confirmingcompliance with the conditions of Corporate Governance formspart of the Annual Report.
The Board of Directors of the Company have adopted a Code ofConduct and the same has been hosted on the Company's websiteat Code of Conduct. The Directors and senior managementpersonnel have affirmed their compliance with the Code of Conductfor the financial year ended 31st March, 2025.
The Company does not fall within the top 1000 listed entitiesbased on the market capitalization as on 31st December, 2024.Hence, during the year under review, in terms of Regulation34(2)(f) of the SEBI Listing Regulations, the requirement ofBusiness Responsibility and Sustainability Report ('BRSR') is notapplicable to the Company.
During the year under review, your Company transferred an amountof '15,65,213.68, arising out of the sale proceeds of fractionalentitlement from the Composite Scheme of Arrangement amongstBorosil Limited ("Demerged Company” / "BL") and the Company(“Resulting Company" / "Transferee Company") and BorosilTechnologies Limited ("Transferor Company" / "BTL") ("Scheme")to Investor Education and Protection Fund. The details of shareslying in the unclaimed suspense account and unclaimed suspenseescrow account are disclosed in the Corporate Governance Report,which forms part of this Annual Report.
Board of Directors
During the year under review, the Board, based on therecommendation of the Nomination & Remuneration Committee,and after taking into account the expertise and experience,re-appointed Mr. Kewal Kundanlal Handa (DIN: 00056826) andMrs. Anupa Rajiv Sahney (DIN: 00341721), as Independent Directorson the Board of your Company, for second term of 5 consecutiveyears commencing from 1st March, 2025. The Members approvedthe said re-appointments through the resolutions passed by PostalBallot with requisite majority on 23rd January, 2025.
In terms of the Regulation 17(1A) of the SEBI Listing Regulations,consent of the Members by way of Special Resolution is requiredfor continuation of a Non-Executive Director beyond the age of 75years. Mr. Pradeep Kumar Kheruka (DIN: 00016909), Non-ExecutiveDirector of the Company, will attain the age of 75 years on 23rd July,2026, and accordingly, the Board, on the recommendation of theNomination & Remuneration Committee, has recommended thecontinuation of Mr. Pradeep Kumar Kheruka as a Non-ExecutiveDirector of the Company even after attaining the age of 75 years,liable to retire by rotation.
Further, in accordance with the provisions of the Act and theArticles of Association of the Company, Mr. Shreevar Kheruka(DIN: 01802416), Director of the Company, retires by rotation at theensuing Annual General Meeting and being eligible, have offeredhimself for re-appointment. The Board of Directors of the Company,based on the recommendation of the Nomination & RemunerationCommittee, have recommended his re-appointment.
The resolution seeking Member's approval for the aboveappointment / re-appointment of Directors along with thedisclosures required pursuant to Regulation 36 of the SEBI ListingRegulations and the Secretarial Standards-2 on General Meetingsforms part of the Notice of the ensuing 34th AGM.
Independent Directors & declaration of their Independence
The Company has 3 (three) Independent Directors, namely,Mr. Kewal Kundanlal Handa, Mrs. Anupa Rajiv Sahney andMr. Chandra Kishore Mishra.
All Independent Directors of the Company have given declarationsunder Section 149(7) of the Act, that they meet the criteria ofindependence as laid down under Section 149(6) of the Actand Regulation 16(1 )(b) of the SEBI Listing Regulations. Interms of Regulation 25(8) of the SEBI Listing Regulations, theIndependent Directors have confirmed that they are not aware ofany circumstance or situation, which exists or may be reasonablyanticipated, that could impair or impact their ability to dischargetheir duties with an objective independent judgement and withoutany external influence.
The Board of Directors of the Company have taken on recordthe declaration and confirmation submitted by the IndependentDirectors after undertaking due assessment of the veracity of thesame. The Independent Directors have also confirmed that theyhave complied with Schedule IV to the Act and the Company'sCode of Conduct. There has been no change in the circumstancesaffecting their status as Independent Directors of the Company.The Board of Directors believes that the Company's IndependentDirectors are distinguished professionals, possessing deepexpertise and extensive experience across a broad range of areas.They uphold the highest standards of integrity and maintain theirindependence from the management.
The Company has also received confirmation from the IndependentDirectors of the Company regarding the registration of their namesin the databank maintained by the Indian Institute of CorporateAffairs in terms of Rule 6 of the Companies (Appointment andQualification of Directors) Rules, 2014.
Familiarization Program for Independent Directors
The details of familiarization program conducted for IndependentDirectors are provided in the Corporate Governance Report, whichforms part of this Annual Report.
Number of Board Meetings
During the year under review, four (4) meetings of Board of Directorswere held i.e. on 21st May, 2024, 13th August, 2024, 12th November,2024, and 11th February, 2025. The Director's attendance is detailedin the Corporate Governance Report, which forms part of thisAnnual Report.
Board Evaluation
The Company has devised a framework for performance evaluationof the Board, its Committees and Individual Directors includingIndependent Directors, in compliance with the provisions of
Sections 134 & 178 of the Act, Regulation 17(10) of the SEBI ListingRegulations and the Nomination and Remuneration Policy of theCompany.
Structured questionnaires were circulated for providing feedbackon the functioning of the Board, its Committees & IndividualDirectors, including Chairman and Independent Directors. Theobservations and feedback from the Directors were discussed andthe summary of the same was presented to the Board.
Evaluation criteria included attendance, participation, integrity,knowledge, independence, and overall contribution to governance.The Board's and Committee's evaluation focused on structure,independence, governance, compliance, strategic oversight,effectiveness and decision-making.
The Directors expressed their satisfaction with the evaluationprocess and the performance evaluation of the Board, itsCommittees and Directors including Independent Directors.
During the year under review, Ms. Vidhi Sanghvi, Company Secretaryand Compliance Officer of the Company and Mr. Rajesh Agrawal,Chief Financial Officer of the Company stepped down from theirrespective positions w.e.f. 21st May, 2024 and 13th August, 2024,respectively.
The Board of Directors, at their Meeting held on 21st May, 2024and 13th August, 2024, appointed Mr. Sanjay Gupta, as CompanySecretary and Compliance Officer of the Company and Mr. SomnathBillur as Chief Financial Offer of the Company, respectively.
The Company has devised and adopted, inter alia, a policy onDirector's appointment and remuneration including Key ManagerialPersonnel, Senior Management and Other Employees. This policyoutlines the guiding principles for the Nomination & RemunerationCommittee for identifying persons who are qualified to becomeDirectors and to determine the independence of Directors, whileconsidering their appointment as Directors of the Company andthat remuneration is directed towards rewarding performancebased on individual as well as organizational achievements andindustry benchmarks.
The aforesaid policy is available on the website of the Company atNomination and Remuneration Policy.
The Company recognizes and embraces the importance of adiverse Board in its success. The Company believes that a trulydiverse Board will leverage differences in thought, perspective,knowledge, skill, regional and industry experience, cultural andgeographical backgrounds, age, ethnicity, race and gender, whichwill help the Company retain a competitive advantage. The Policyon the Diversity of the Board of Directors adopted by the Board,sets out its approach to diversity.
As on 31st March, 2025, the Board has following statutoryCommittees according to their respective roles and defined scope:
a) Audit Committee
b) Nomination & Remuneration Committee
Qtali'pihnlrlpirc' Dolatinnchin r'.r\mmittpp
d) Corporate Social Responsibility Committee
e) Risk Management Committee
During the year under review, the Board of Directors accepted allrecommendations made by the Committees of the Board, with noinstances of non-acceptance.
The details of composition of the Board and its Committees,number of meetings held, attendance of Board and CommitteesMembers at such meetings, including the terms of reference ofthe Committees are provided in the Corporate Governance Report,which forms part of this Annual Report.
The composition and terms of reference of all the Committeesof the Company are in line with the provisions of the Act and theSEBI Listing Regulations.
Amid continuous shift in business paradigm marked by geopoliticalshifts, technological disruptions, regulatory changes, and marketvolatility, effective risk management has become essential forsustainable business performance. The Company acknowledgesthe range of potential risks and remains committed to proactivelymanaging such risks to facilitate the achievement of businessobjectives.
With this context in mind, the Company has developed and adoptedan Enterprise Risk Management ("ERM”) Policy and framework,benchmarked with leading international risk managementstandards such as ISO 31000:2018 and Committee of SponsoringOrganization of the Treadway Commission ("COSO”) - 2017 ERMIntegrated Framework. The ERM Policy and Framework outlinesthe roles and responsibilities of key stakeholders across theorganization to strengthen risk governance; establishes processesof risk management viz., Risk Identification, Assessment,Prioritization, Mitigation, Monitoring and Reporting; and facilitatesa coordinated and integrated approach for managing Risks &Opportunities across the organization. The management teamsacross businesses and functions analyzes risks in their operationsand related to their strategic objectives, at least bi-annually,considering bottom up risk assessment, an external outlook andtop management input.
In accordance with the provisions of Regulation 21 of theSEBI Listing Regulations, the Board has voluntarily formed a RiskManagement Committee. The Risk Management Committeeconducts integrated risk and performance reviews on bi-annualbasis along with the Senior Executives engaged in differentbusiness divisions and functions.
The Committee reviews the top identified enterprise level risks andthe effectiveness of the existing controls and developed mitigationplans to provide feedback and guidance on treatment andmitigation of the existing and emerging risks. The Risk ManagementCommittee has also adopted the practice of reviewing Key RiskIndicators (KRIs) to facilitate in-depth analysis of the identifiedrisks, evaluating the adequacy of existing risk managementsystems and advising for any additional actions and areas ofimprovement required for effective implementation of the ERMPolicy and Framework. The Committee also ensures the allocationof sufficient resources for the business to effectively mitigate keyrisks and ensure that business value is safeguarded and enhancedconsistently. The overall ERM program developed by the Companyrests on the foundation of continuous training and developmentof employees across all the levels on risk management practices
to enhance the awareness of ERM framework and foster a cultureof risk informed decision-making. The Company is resolute in itsefforts to keep the Risk Management Policy efficient and relevant.In line with this commitment, a comprehensive review of the existingERM Policy was undertaken during the year and the revised policywas reviewed and approved by the Risk Management Committee.
Your Company has robust framework for identification andmonitoring of all related party transactions. Any potential or actualconflict of interest that may arise because of entering into suchtransactions are promptly informed to the Audit Committee. TheCompany's Policy on Related Party Transactions, as approved bythe Board, is available on the website of the Company and can beaccessed at Policy on Related Party Transactions.
During the year under review, all contracts / arrangements /transactions entered by the Company with related parties werein the ordinary course of business and on arm's length basis.Contracts / arrangements / transactions were entered into withrelated parties in accordance with the Policy on Related PartyTransactions.
The Company had not entered into any contract / arrangement /transaction with related parties which is required to be reported inForm No. AOC-2 in terms of Section 134(3)(h) read with Section188 of the Act and Rule 8(2) of the Companies (Accounts) Rules,2014.
Members may refer to the notes on Related Party Transactionsforming part of Standalone Financial Statement which sets out thedisclosures pursuant to Ind AS.
The Company believes in inclusive growth to facilitate creation ofa value based and empowered society through continuous andpurposeful engagement with society. All our CSR initiatives areapproved by the CSR Committee in line with the Company's CSRPolicy and is reviewed periodically.
The details of contribution made by the Company during the yearunder review towards the CSR activities are as under:
Sr.
No.
CSR Project or activity
Amountspentduring FY2024-25(' in lakhs)
1
Promoting health care including preventivehealth care - contribution to Shree SardarVallabhbhai Patel Rotary General Hospital fordevelopment & enhancement of the UrologyDepartment
37.00
TOTAL
The Annual Report on CSR activities in terms of Rule 8 of theCompanies (Corporate Social Responsibility) Rules, 2014 isattached herewith as an ‘Annexure - B’ to this Report. For otherdetails regarding the CSR Committee, please refer to the CorporateGovernance Report, which forms part of this Annual Report. TheCSR Policy is uploaded on the website of the Company and can beaccessed at CSR Policy.
The Annual Return of the Company in Form MGT-7 as on 31st March,2025 for FY 2024-25 as per provisions of the Section 92(3) readwith Section 134(3)(a) of the Act and the Rules framed thereunder,is available on the Company's website and can be accessed atAnnual Return.
The Company promotes safe, ethical and compliant conductacross all its business activities and has put in place a mechanismfor reporting illegal or unethical behavior. The Company hasestablished a robust Vigil Mechanism and Whistle Blower / VigilMechanism Policy in accordance with the provisions of the Actand the SEBI Listing Regulations to deal with instances of fraudand mismanagement. Employees and other stakeholders areencouraged to report actual or suspected violations of applicablelaws and regulations and the Code of Conduct. Additional detailsabout the Whistle Blower / Vigil Mechanism Policy of the Companyare explained in the Corporate Governance Report, which formspart of this Annual Report.
A Whistle Blower / Vigil Mechanism Policy is available on theCompany's website and can be accessed at Whistle Blower / VigilMechanism Policy.
Statutory Auditor
M/s. Chaturvedi & Shah LLP, Chartered Accountants (FirmRegistration No.101720W/W100355) were appointed as StatutoryAuditor for a term of 5 (five) consecutive years at the 32nd AnnualGeneral Meeting held on 17th August, 2023. The Auditor hasconfirmed that they are not disqualified from continuing as Auditorof the Company.
The Auditors' Report does not contain any qualification, reservation,adverse remark or disclaimer. The Notes to the financial statementsreferred in the Auditors' Report are self-explanatory and do not callfor any further comments.
Cost Records and Audit
During the year under review, maintenance of cost records and therequirement of cost audit, as prescribed under the provisions ofSection 148 of the Act and Rules made thereunder, did not applyto the Company.
Secretarial Auditor
The Board has appointed M/s. Amogh Diwan & Associates,Practicing Company Secretaries, to conduct the Secretarial Auditof the Company. The Secretarial Audit Report for the financial yearended 31st March, 2025 is annexed and marked as 'Annexure - C’to this Report. The Secretarial Audit Report does not contain anyqualification, reservation, adverse remark or disclaimer.
The Secretarial Audit report of the Company's material subsidiaryi.e. Goel Scientific Glass Works Limited is also annexed and markedas 'Annexure - Cl’ to this Report.
Pursuant to the amended provisions of Regulation 24A of the SEBIListing Regulations and Section 204 of the Act read with Rule 9of the Companies (Appointment and Remuneration of ManagerialPersonnel) Rules, 2014, the Board, based on the recommendationof the Audit Committee, have approved and recommended the
OTHER DISCLOSURES
a) There has been no change in the nature of business of theCompany during the year under review.
b) No Director of the Company is in receipt of any remunerationor commission from any of its subsidiaries, except for thesitting fees for attending the Board and Committee Meetingsof Subsidiary Company.
c) No significant or material orders were passed by theRegulators or Courts or Tribunals which impact the goingconcern status and Company's operations in future.
d) The Company does not have any scheme or provision ofproviding money for the purchase of its own shares byemployees or by trustees for the benefit of employees.
e) The Company has not accepted any deposits from the publicfalling within the meaning of the provisions of Sections 73and 76 of the Act and the Rules framed thereunder.
appointment of M/s. Amogh Diwan & Associates, Peer ReviewedFirm of Company Secretaries in Practice (Firm Registration Number:S2019MH668700) as Secretarial Auditor of the Company for a termof upto 5 (five) consecutive years, to conduct the secretarial auditfor the financial years 2025-26 up to 2029-30, for approval of theMembers at ensuing AGM of the Company.
Brief resume and other details of M/s. Amogh Diwan & Associatesare separately disclosed in the Notice of ensuing AGM.The resolution seeking approval of the Members for the appointmentof M/s. Amogh Diwan & Associates, for a term of 5 consecutiveyears, has been incorporated in the Notice of the ensuing AGM.
During the year under review, the Statutory and Secretarial Auditorhave not reported any instances of frauds committed in theCompany by its officers or employees, to the Audit Committeeunder Section 143(12) of the Act.
Based on the disclosures provided in the Annual Accounts and asper the discussions with the Statutory Auditor of the Company, theBoard of Directors confirm that:
a) in the preparation of the annual accounts for the year ended31st March, 2025, the applicable accounting standards readwith requirements set out under Schedule III to the Act havebeen followed and there were no material departures fromthe same;
b) the Directors have selected such accounting policies andapplied them consistently and made judgements andestimates that are reasonable and prudent so as to give atrue and fair view of the state of affairs of the Company as at31st March, 2025 and of the profit of the Company for the yearended on that date;
c) the Directors have taken proper and sufficient care for themaintenance of adequate accounting records in accordancewith the provisions of the Act for safeguarding the assetsof the Company and for preventing and detecting fraud andother irregularities;
d) the Directors have prepared the annual accounts on a goingconcern basis;
e) the Directors have laid down internal financial controls tobe followed by the Company and that such internal financialcontrols are adequate and are operating effectively; and
f) the Directors have devised proper systems to ensurecompliance with the provisions of all applicable laws and thatsuch systems are adequate and operating effectively.
The Company has adequate Internal Financial Control systemcommensurate with its size and nature of business. The internalcontrol systems are designed to ensure that the financialstatements are prepared based on reliable information andwherever possible, the key internal financial controls have beenautomated. The Company has also engaged a third party to reviewthe existing internal financial controls and suggest necessaryimprovements / enhancements to strengthen the same. InternalAudits are continuously conducted by internal audit team of the
Company and Internal Audit Reports are reviewed by the AuditCommittee on quarterly basis.
Particulars of loans given by the Company during the year underreview are provided in ‘Annexure - D’ to this report. Members mayrefer to the notes forming part of Standalone Financial Statement.
The Company has not made any investments nor provided anyguarantee/ security during the year under review.
The Company has in place a Policy for Prevention, Prohibitionand Redressal of Sexual Harassment at work place, which is inline with the requirements of the Sexual Harassment of womenat the Workplace (Prevention, Prohibition and Redressal) Act,2013 ("POSH Act") and Rules made thereunder. All employees(permanent, contractual, temporary and trainees) are coveredunder this Policy. The Company has constituted Internal ComplaintCommittees for its various offices & plants under Section 4 of thePOSH Act to redress and resolve any complaints arising under thesaid Act. The Company has submitted the necessary reports to theconcerned authority(ies) confirming the same.
The disclosures pertaining to remuneration and other details asrequired pursuant to Section 197(12) of the Act read with Rule 5(1)of the Companies (Appointment and Remuneration of ManagerialPersonnel) Rules, 2014 are attached as ‘Annexure - E’ to thisreport.
In terms of the provisions of Section 197(12) of the Act readwith Rules 5(2) and 5(3) of the Companies (Appointmentand Remuneration of Managerial Personnel) Rules, 2014, astatement showing the names of the top ten employees in termsof remuneration drawn and names and other particulars of theemployees drawing remuneration in excess of the limits set out inthe said rules, forms part of this Report. In accordance with theprovisions of Section 136 of the Act, this Annual Report and theAudited Financial Statements are being sent to the Members andothers entitled thereto, excluding the aforesaid statement. Thesaid statement is available for inspection electronically by theMembers of the Company. Any Member interested in obtaininga copy thereof may write to the Company Secretary atbsl.secretarial@borosil.com.
The information pertaining to the conservation of energy,technology absorption, foreign exchange earnings and outgo, asrequired to be disclosed under Section 134(3)(m) of the Act readwith Rule 8(3) of the Companies (Accounts) Rules, 2014 for thefinancial year ended 31st March, 2025 is provided in ‘Annexure - F’to this Report.
The Company is in compliance with the applicable SecretarialStandards, i.e. SS-1 and SS-2, relating to 'Meetings of the Boardof Directors' and 'General Meetings', respectively, issued by theInstitute of Company Secretaries of India.
f) There has been no issue of shares (including sweat equityshares) to employees of the Company under any schemesave and except Employees' Stock Options Schemes referredto in this Report.
g) There has been no application made or proceeding pendingunder the Insolvency and Bankruptcy Code, 2016, as amendedfrom time to time.
h) There was no instance of onetime settlement with any Bankor Financial Institution.
The Directors appreciate the hard work, dedication, andcommitment of all the employees of the Company. The Directorsextend their sincere gratitude to the members, government andregulatory authorities, banks, rating agencies, stock exchanges,depositories, auditors, customers, vendors, business partners,suppliers, distributors, communities in the neighborhood of theCompany's operations and other stakeholders for their continuoussupport and the confidence they have placed in the Management.
For and on behalf of the Board of Directors
Kewal Kundanlal Handa Vinayak Madhukar Patankar
Place: Mumbai Chairman Whole-time Director & CEO
Date: 21st May, 2025 DIN: 00056826 DIN: 07534225